NF-1 associated malignant peripheral nerve sheath tumors (MPNST)—Delucravatinib associated with Mirdametinib, a MEK-inhibitor, showed an inhibitory effect on cell proliferation and induced apoptosis in vitro [52]. This evidence concerns the gene MAP2K7 and malignant peripheral nerve sheath tumor.